Inovio Pharmaceuticals Statistics
Total Valuation
INO has a market cap or net worth of $260.92 million. The enterprise value is $168.73 million.
| Market Cap | 260.92M |
| Enterprise Value | 168.73M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, after market close.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
INO has 25.91 million shares outstanding. The number of shares has increased by 8.15% in one year.
| Shares Outstanding | 25.91M |
| Shares Change (YoY) | +8.15% |
| Shares Change (QoQ) | +2.45% |
| Owned by Insiders (%) | 0.84% |
| Owned by Institutions (%) | 17.59% |
| Float | 25.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 363.87 |
| Forward PS | 609.17 |
| PB Ratio | 2.76 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 235.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.77, with a Debt / Equity ratio of 0.14.
| Current Ratio | 4.77 |
| Quick Ratio | 4.62 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -113.92 |
Financial Efficiency
Return on equity (ROE) is -96.20% and return on invested capital (ROIC) is -121.88%.
| Return on Equity (ROE) | -96.20% |
| Return on Assets (ROA) | -68.80% |
| Return on Capital (ROIC) | -121.88% |
| Revenue Per Employee | $5,878 |
| Profits Per Employee | -$1.02M |
| Employee Count | 122 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.82% in the last 52 weeks. The beta is 0.90, so INO's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +45.82% |
| 50-Day Moving Average | 9.94 |
| 200-Day Moving Average | 8.17 |
| Relative Strength Index (RSI) | 53.40 |
| Average Volume (20 Days) | 558,644 |
Short Selling Information
The latest short interest is 2.04 million, so 7.86% of the outstanding shares have been sold short.
| Short Interest | 2.04M |
| Short Previous Month | 1.87M |
| Short % of Shares Out | 7.86% |
| Short % of Float | 7.98% |
| Short Ratio (days to cover) | 4.78 |
Income Statement
In the last 12 months, INO had revenue of $717,068 and -$124.94 million in losses. Loss per share was -$5.48.
| Revenue | 717,068 |
| Gross Profit | 717,068 |
| Operating Income | -131.47M |
| Pretax Income | -124.94M |
| Net Income | -124.94M |
| EBITDA | -120.74M |
| EBIT | -123.85M |
| Loss Per Share | -$5.48 |
Balance Sheet
The company has $105.61 million in cash and $13.43 million in debt, giving a net cash position of $92.19 million or $3.56 per share.
| Cash & Cash Equivalents | 105.61M |
| Total Debt | 13.43M |
| Net Cash | 92.19M |
| Net Cash Per Share | $3.56 |
| Equity (Book Value) | 94.44M |
| Book Value Per Share | 3.64 |
| Working Capital | 88.28M |
Cash Flow
In the last 12 months, operating cash flow was -$116.46 million and capital expenditures $88,770, giving a free cash flow of -$116.37 million.
| Operating Cash Flow | -116.46M |
| Capital Expenditures | 88,770 |
| Free Cash Flow | -116.37M |
| FCF Per Share | -$5.00 |
Margins
Gross margin is 100.00%, with operating and profit margins of -18,334.78% and -17,423.44%.
| Gross Margin | 100.00% |
| Operating Margin | -18,334.78% |
| Pretax Margin | -17,423.44% |
| Profit Margin | -17,423.44% |
| EBITDA Margin | -16,837.96% |
| EBIT Margin | -17,271.83% |
| FCF Margin | -16,228.90% |
Dividends & Yields
INO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.15% |
| Shareholder Yield | -8.15% |
| Earnings Yield | -47.88% |
| FCF Yield | -44.60% |
Analyst Forecast
The average price target for INO is $19.60, which is 94.64% higher than the current price. The consensus rating is "Buy".
| Price Target | $19.60 |
| Price Target Difference | 94.64% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 229.75% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jan 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
INO has an Altman Z-Score of -15.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.75 |
| Piotroski F-Score | 3 |